In the context of Duchenne muscular dystrophy (DMD)—related cardiomyopathy—patient-derived iPSC-CMs have been utilized to evaluate exon-skipping oligonucleotides and CRISPR-mediated gene editing approaches aimed at restoring dystrophin expression [146,147]. Here, DMD is linked to Duchenne muscular dystrophy.